We assist with everything from developing an appropriate scope of protection for new molecules, new formulations, or new medical uses of already known drugs, to handling the exceptions in patent law regarding medical use claims. For pharmaceuticals, there are also many other considerations beyond patent protection. These include various types of market exclusivities such as data exclusivity for clinical trials, orphan drugs, and pediatric exclusivity. In addition to these, we also handle other important intellectual property aspects for pharmaceuticals such as the Orange Book for FDA-approved drugs in the USA. We also have extensive experience in conducting Freedom-to-Operate analyses regarding pharmaceuticals, where factors such as API, formulation, and manufacturing need to be considered.